Dow Down 0.92% Nasdaq Down 0.83%

Novavax, Inc. (NVAX)

-NasdaqGS
4.85 0.14(2.81%) Oct 22, 4:00PM EDT
Prev Close:4.99
Open:4.98
Bid:2.73 x 300
Ask:5.05 x 100
1y Target Est:10.07
Beta:1
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.84 - 5.03
52wk Range:2.68 - 6.95
Volume:2,957,368
Avg Vol (3m):3,238,220
Market Cap:1.15B
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXDown 2.81%1.15B
MRK160.13B
NVS213.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback